1. Home
  2. STG vs SRZN Comparison

STG vs SRZN Comparison

Compare STG & SRZN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sunlands Technology Group

STG

Sunlands Technology Group

N/A

Current Price

$5.80

Market Cap

112.4M

Sector

Real Estate

ML Signal

N/A

Logo Surrozen Inc.

SRZN

Surrozen Inc.

HOLD

Current Price

$16.08

Market Cap

117.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
STG
SRZN
Founded
2003
2015
Country
China
United States
Employees
N/A
N/A
Industry
Other Consumer Services
Medicinal Chemicals and Botanical Products
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
112.4M
117.8M
IPO Year
2018
N/A

Fundamental Metrics

Financial Performance
Metric
STG
SRZN
Price
$5.80
$16.08
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$38.50
AVG Volume (30 Days)
7.4K
110.4K
Earning Date
11-20-2025
11-07-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
4.01
N/A
Revenue
$285,589,112.00
$3,604,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$1.45
N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.28
$5.90
52 Week High
$15.00
$18.17

Technical Indicators

Market Signals
Indicator
STG
SRZN
Relative Strength Index (RSI) 44.53 66.35
Support Level $4.84 $12.79
Resistance Level $5.99 $16.75
Average True Range (ATR) 0.41 0.97
MACD 0.07 0.42
Stochastic Oscillator 44.91 85.95

Price Performance

Historical Comparison
STG
SRZN

About STG Sunlands Technology Group

Sunlands Technology Group is a provider of online post-secondary and professional education services in China. The company offers various degree- and diploma-oriented post-secondary courses through its online platforms. In addition, it provides online professional courses and educational content to help students prepare for professional certification exams and attain professional skills. The Group has one operating segment, which is the provision of online education services.

About SRZN Surrozen Inc.

Surrozen Inc is a clinical-stage biotechnology company committed to discovering and developing drug candidates to selectively modulate the Wnt pathway, a critical mediator of tissue repair, in a broad range of organs and tissues. Its product candidate includes SZN-1326 (Fzd5/Lrp6, SWAP), SZN-413 and SZN-043 (E3/ASGR1, SWEETS).

Share on Social Networks: